AXDX Analyst Estimates: Price Targets, Revenue, Net Income, and EBIT Forecast - Accelerate Diagnostics Inc - Alpha Spread

Accelerate Diagnostics Inc
NASDAQ:AXDX

Watchlist Manager
Accelerate Diagnostics Inc Logo
Accelerate Diagnostics Inc
NASDAQ:AXDX
Watchlist
Price: 1.51 USD -0.66% Market Closed
Market Cap: 35.7m USD
Have any thoughts about
Accelerate Diagnostics Inc?
Write Note

Wall Street
Price Targets

AXDX Price Targets Summary
Accelerate Diagnostics Inc

Wall Street analysts forecast AXDX stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AXDX is 1.5 USD .

Lowest
Price Target
Not Available
Average
Price Target
1.5 USD
1% Downside
Highest
Price Target
Not Available
Accelerate Diagnostics Inc Competitors:
Price Targets
AORT
Artivion Inc
21% Upside
HOLX
Hologic Inc
9% Upside
NVNO
enVVeno Medical Corp
241% Upside
179290
MITech Co Ltd
21% Upside
287410
Jeisys Medical Inc
14% Upside
NVCR
Novocure Ltd
56% Upside
338220
Vuno Inc
44% Upside
688617
APT Medical Inc
7% Upside

Revenue
Forecast

Revenue Estimate
Accelerate Diagnostics Inc

For the last 8 years the compound annual growth rate for Accelerate Diagnostics Inc's revenue is 73%. The projected CAGR for the next 2 years is 3%.

73%
Past Growth
3%
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Accelerate Diagnostics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Accelerate Diagnostics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-45%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AXDX's stock price target?
Price Target
1.5 USD

According to Wall Street analysts, the average 1-year price target for AXDX is 1.5 USD .

What is Accelerate Diagnostics Inc's Revenue forecast?
Projected CAGR
3%

For the last 8 years the compound annual growth rate for Accelerate Diagnostics Inc's revenue is 73%. The projected CAGR for the next 2 years is 3%.

Back to Top